Genmab A (GMAB) Operating Margin (2018 - 2026)

Genmab A (GMAB) reported Operating Margin of 20.09% for Q1 2026, down 620.0% on a YoY basis from 3.86% in Q1 2025, and down 55.27% quarter-over-quarter from 44.91% in Q3 2025.

Genmab A (GMAB) Operating Margin (2018 - 2026) Analysis & Trends

Genmab A has reported Operating Margin for 6 years, with the latest figure at 20.09% in Q1 2026.

  • For the quarter ending Q1 2026, Operating Margin fell 620.0% year-over-year to 20.09%; the trailing twelve-month figure through Mar 2026 stood at 33.36% (up 418.0% YoY), and the FY2025 full-year result was 28.63%, down 251.0% from the prior year.
  • Operating Margin for Q1 2026 stood at 20.09%, down from 44.91% in the prior quarter.
  • The five-year high for Operating Margin was 44.91% in Q3 2025, with the low at 19.24% in Q1 2024.
  • Historically, Operating Margin has averaged 31.11% across 3 years, with a median of 30.3% in 2024.
  • Annual changes were most pronounced in 2025 — Operating Margin jumped 862 bps — and 2026, when it sank 620 bps.
  • Genmab A's Operating Margin stood at 37.99% in 2024, then advanced by 18 bps to 44.91% in 2025, then slumped by 55 bps to 20.09% in 2026.
  • The last three Operating Margin figures came in at 20.09% (Q1 2026), 44.91% (Q3 2025), and 38.92% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 38.10%
9 Abivax 94.26 Bn 94.26 Bn - -
10 Genmab A 48.34 Bn 46.82 Bn 831.00 Mn 20.09%

Historic Data

Download Data
DateValue
Mar 31, 2026 20.09%
Sep 30, 2025 44.91%
Jun 30, 2025 38.92%
Mar 31, 2025 26.29%
Sep 30, 2024 37.99%
Jun 30, 2024 30.30%
Mar 31, 2024 19.24%
Sep 30, 2020 49,767,981.44%
Dec 31, 2019 33.75%
Sep 30, 2019 0.00%
Dec 31, 2018 33.44%